Benefit finding in men affected by prostate cancer prior to and following radical prostatectomy – a cross-sectional study with a stratified sample

Table 3 Simple regression analysis for benefit finding prior to and following surgery

	Pre-surgery (n = 212)				Post-surgery (n = 2086)
	B	SE	ß	p-value	B	SE	ß	p-value
Sociodemographic factors
Age at survey (years) (continuous)	-0.0036	0.0078	-0.0189	0.64	-0.0058	0.0025	-0.0505	0.02
Partnership (ref. no)	0.0872	0.3671	0.0249	0.81	0.145	0.0609	0.0536	0.02
Children(ref. no)	0.2112	0.1677	0.0881	0.21	0.1237	0.0561	0.0519	0.03
Clinical characteristics
Second primary cancer(ref. no)	-0.2418	0.2841	-0.0586	0.40	-0.0551	0.0755	-0.016	0.47
Family history of PCa(ref. no)	-0.0895	0.1282	-0.0481	0.49	-0.0397	0.0445	-0.0196	0.37
RCS Charlson Score (at surgery)(continuous)	0.2096	0.1061	0.135	0.05	0.042	0.0379	0.0242	0.27
PSA Lever at diagnosis (ref. ≤4)				0.94				0.94
> 4 ≤ 10	0.0069	0.1956	0.0037		-0.0158	0.0709	-0.0083
> 10	0.0527	0.2129	0.0261		-0.0013	0.0758	-0.0007
Psychosocial factors
Perceived severity of disease(continuous)	0.1789	0.0664	0.1875	0.008	0.1495	0.0202	0.1609	< 0.0001
Depressive symptoms (PHQ-2)(ref. negative screening (< 3))	-0.1354	0.3074	-0.031	0.66	-0.0067	0.0686	-0.0021	0.92
Anxiety symptoms (GAD-2)(ref. negative screening (< 3))	0.2642	0.2427	0.0764	0.28	-0.0512	0.077	-0.0147	0.51
Distress (QSC-R10(ref. low < 15)	0.0186	0.0086	0.155	0.03	0.0093	0.0023	0.0893	< 0.0001
Psychosocial counseling desired(ref. no)	0.0296	0.186	0.0114	0.87	0.1596	0.0489	0.0722	0.001
Quality of life (QLQ-C30)(continuous)	-0.0387	0.0428	-0.0637	0.37	0.0189	0.0107	0.0389	0.08

Note: B, parameter estimate; SE, standard error; ß, standardized parameter estimate, ref., reference; PCa, prostate cancer; PSA, prostate specific antigen; RCS, Royal College of Surgeons; PHQ, patient health questionnaire; GAD, general anxiety disorder; highlighted factors indicate statistical significance (p < 0.01).

ISSN: 1471-2407